{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:58:25Z","timestamp":1648688305481},"reference-count":51,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1684\/bdc.2012.1628","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T20:01:59Z","timestamp":1565726519000},"page":"881-888","source":"Crossref","is-referenced-by-count":0,"title":["M\u00e9lanome cutan\u00e9 de l\u2019enfant : particularit\u00e9s diagnostiques et th\u00e9rapeutiques"],"prefix":"10.1016","volume":"99","author":[{"given":"Yves","family":"R\u00e9guerre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Fran\u00e7oise","family":"Avril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Fraitag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Bodemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2012.1628_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/S0959-8049(01)00006-5","article-title":"Childhood melanoma in Europe since 1978: a population-based survival study","author":"Conti","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1684\/bdc.2012.1628_bib0010","first-page":"1061","article-title":"Epidemiology of childhood cancers","volume":"57","author":"Clavel","year":"2007","journal-title":"Rev Prat"},{"key":"10.1684\/bdc.2012.1628_bib0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/CEJ.0b013e32833876c0","article-title":"Incidence of childhood cancer in France: National Children Cancer Registries, 2000-2004","volume":"19","author":"Lacour","year":"2010","journal-title":"Eur J Cancer Prev"},{"key":"10.1684\/bdc.2012.1628_bib0020","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1200\/JCO.2005.02.899","article-title":"Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database","volume":"23","author":"Strouse","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2012.1628_bib0025","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1200\/JCO.2006.08.8310","article-title":"Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base","volume":"25","author":"Lange","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2012.1628_bib0030","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.ejca.2006.07.001","article-title":"Skin cancer incidence and survival in European children and adolescents (1978-1997). Report from the Automated Childhood Cancer Information System project","volume":"42","author":"de Vries","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1684\/bdc.2012.1628_bib0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/08880010290057327","article-title":"Cutaneous melanoma in childhood and adolescence","volume":"19","author":"Hamre","year":"2002","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1684\/bdc.2012.1628_bib0040","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ijc.22692","article-title":"Cutaneous malignant melanoma in children and adolescents in Sweden, 1993-2002: the increasing trend is broken","volume":"121","author":"Karlsson","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1684\/bdc.2012.1628_bib0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1586\/era.11.28","article-title":"Trends in melanoma incidence among children: possible influence of sun-protection programs","volume":"11","author":"Baade","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1684\/bdc.2012.1628_bib0050","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1525-1470.2009.00920.x","article-title":"Thin primary cutaneous melanoma in childhood and adolescence: report of 12 cases","volume":"26","author":"Manganoni","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1684\/bdc.2012.1628_bib0055","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1542\/peds.2004-0471","article-title":"Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution","volume":"115","author":"Ferrari","year":"2005","journal-title":"Pediatrics"},{"key":"10.1684\/bdc.2012.1628_bib0060","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jaad.2005.07.013","article-title":"Malignant melanoma in childhood and adolescence: report of 13 cases","volume":"53","author":"Jafarian","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1684\/bdc.2012.1628_bib0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1067\/mjd.2002.120602","article-title":"Congenital and infantile melanoma: review of the literature and report of an uncommon variant, pigment-synthesizing melanoma","volume":"47","author":"Richardson","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1684\/bdc.2012.1628_bib0070","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1200\/JCO.2003.12.149","article-title":"Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant","volume":"21","author":"Alexander","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2012.1628_bib0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/archderm.140.1.83","article-title":"Neonatal giant congenital nevi with proliferative nodules: a clinicopathologic study and literature review of neonatal melanoma","volume":"140","author":"Leech","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1684\/bdc.2012.1628_bib0080","doi-asserted-by":"crossref","unstructured":"Price HN, Schaffer JV. Congenital melanocytic nevi-when to worry and how to treat: facts and controversies. Clin Dermatol ; 28 : 293-302.","DOI":"10.1016\/j.clindermatol.2010.04.004"},{"key":"10.1684\/bdc.2012.1628_bib0085","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s100249900064","article-title":"Melanoma in childhood: review and perspectives","volume":"1","author":"Spatz","year":"1998","journal-title":"Pediatr Dev Pathol"},{"key":"10.1684\/bdc.2012.1628_bib0090","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archderm.135.3.282","article-title":"Spitz tumors in children: a grading system for risk stratification","volume":"135","author":"Spatz","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1684\/bdc.2012.1628_bib0095","first-page":"275","article-title":"Spitz nevus with an uncertain malignant potential","volume":"50","author":"Stanescu","year":"2009","journal-title":"Rom J Morphol Embryol"},{"key":"10.1684\/bdc.2012.1628_bib0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-0560.2008.01077.x","article-title":"Cdc7 expression in melanomas. Spitz tumors and melanocytic nevi","volume":"36","author":"Clarke","year":"2009","journal-title":"J Cutan Pathol"},{"key":"10.1684\/bdc.2012.1628_bib0105","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/modpathol.3800653","article-title":"BRAF and NRAS mutations in spitzoid melanocytic lesions","volume":"19","author":"Fullen","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1684\/bdc.2012.1628_bib0110","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1610-0387.2005.05051.x","article-title":"Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma","volume":"3","author":"Eigentler","year":"2005","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1684\/bdc.2012.1628_bib0115","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2012.1628_bib0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00000478-200201000-00005","article-title":"Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors","volume":"26","author":"Lohmann","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1684\/bdc.2012.1628_bib0125","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/cncr.11074","article-title":"Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients","volume":"97","author":"Su","year":"2003","journal-title":"Cancer"},{"key":"10.1684\/bdc.2012.1628_bib0130","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.humpath.2006.02.001","article-title":"Sentinel lymph node biopsy in patients with \u201catypical Spitz tumors.\u201d A report on 12 cases","volume":"37","author":"Urso","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1684\/bdc.2012.1628_bib0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1053\/j.semdp.2008.04.003","article-title":"Sentinel lymph node biopsy for patients with melanoma--introductory comments","volume":"25","author":"Busam","year":"2008","journal-title":"Semin Diagn Pathol"},{"key":"10.1684\/bdc.2012.1628_bib0140","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1245\/s10434-007-9577-3","article-title":"Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors)","volume":"15","author":"Murali","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1684\/bdc.2012.1628_bib0145","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000372-200308000-00015","article-title":"What do these cells prove?","volume":"25","author":"LeBoit","year":"2003","journal-title":"Am J Dermatopathol"},{"key":"10.1684\/bdc.2012.1628_bib0150","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2012.1628_bib0155","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1245\/s10434-007-9357-0","article-title":"Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy","volume":"14","author":"Dalal","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1684\/bdc.2012.1628_bib0160","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1001\/archsurg.143.9.892","article-title":"Importance of sentinel lymph node biopsy in patients with thin melanoma","volume":"143","author":"Wright","year":"2008","journal-title":"Arch Surg"},{"key":"10.1684\/bdc.2012.1628_bib0165","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1200\/JCO.2010.31.6760","article-title":"Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined rotterdam tumor load and dewar topography criteria.","volume":"29","author":"van der Ploeg","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2012.1628_bib0170","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0190-9622(03)00124-5","article-title":"Placental metastasis of maternal melanoma","volume":"49","author":"Altman","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1684\/bdc.2012.1628_bib0175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.annpat.2009.10.037","article-title":"Placental metastasis of melanoma: a new case and literature review.","volume":"30","author":"Perret-Court","year":"2010","journal-title":"Ann Pathol"},{"key":"10.1684\/bdc.2012.1628_bib0180","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/cncr.20925","article-title":"Malignant melanoma in pregnancy. A population-based evaluation","volume":"103","author":"O\u2019Meara","year":"2005","journal-title":"Cancer"},{"key":"10.1684\/bdc.2012.1628_bib0185","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clindermatol.2008.09.011","article-title":"Childhood melanoma","volume":"27","author":"Jen","year":"2009","journal-title":"Clin Dermatol"},{"key":"10.1684\/bdc.2012.1628_bib0190","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/1078-0432.CCR-1103-3","article-title":"A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma","volume":"10","author":"Kirkwood","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1684\/bdc.2012.1628_bib0195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)61033-8","article-title":"Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial","volume":"372","author":"Eggermont","year":"2008","journal-title":"Lancet"},{"key":"10.1684\/bdc.2012.1628_bib0200","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/cncr.23399","article-title":"Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease","volume":"112","author":"Anaya","year":"2008","journal-title":"Cancer"},{"key":"10.1684\/bdc.2012.1628_bib0205","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/cncr.20860","article-title":"The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma","volume":"103","author":"Navid","year":"2005","journal-title":"Cancer"},{"key":"10.1684\/bdc.2012.1628_bib0210","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/jnci\/djq009","article-title":"Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis","volume":"102","author":"Mocellin","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1684\/bdc.2012.1628_bib0215","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0305-7372(03)00074-4","article-title":"Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials","volume":"29","author":"Wheatley","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"10.1684\/bdc.2012.1628_bib0220","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ejca.2004.04.030","article-title":"Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?","volume":"40","author":"Eggermont","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1684\/bdc.2012.1628_bib0225","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1200\/JCO.2000.18.1.158","article-title":"Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma","volume":"18","author":"Middleton","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2012.1628_bib0230","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.1999.17.7.2105","article-title":"High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993","volume":"17","author":"Atkins","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2012.1628_bib0235","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/jid.2008.422","article-title":"Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT","volume":"129","author":"Daniotti","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1684\/bdc.2012.1628_bib0240","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma.","volume":"363","author":"Flaherty","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2012.1628_bib0245","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved Survival with Vemurafenib in Melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2012.1628_bib0250","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2012.1628_bib0255","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus Dacarbazine for previously untreated metastatic melanoma","volume":"363","author":"Robert","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115304082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115304082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T08:31:49Z","timestamp":1602491509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115304082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0007455115304082"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2012.1628","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}